About
Reviews
Community
14th World Bispecific Summit 2023
02
Oct
-
04
Oct
2023
When
Boston
USA
Where

Join us for the 14th World Bispecific Summit in 2023, where we celebrate the remarkable advancements and immense potential of bispecific antibody treatments. In this pivotal year, bispecific antibody therapies have emerged as formidable contenders in the field, rivaling cell therapy as a transformative approach in healthcare. With an increasing number of assets progressing through clinical trials, gaining regulatory approval, and expanding their scope of application, the time has never been more exciting for this cutting-edge technology.

Our summit offers a comprehensive program designed to address key challenges at every stage of bispecific antibody development, from discovery and pre-clinical research to clinical trials, regulatory considerations, and combination strategies. Led by the industry's brightest minds, including distinguished experts from Sanofi, Regeneron, the FDA, Alligator Biosciences, and Amgen, this event serves as a perfect platform for celebrating achievements, tackling obstacles, and forging connections with leading figures from the pharmaceutical, biotechnology, and academic fields.

Delve deep into novel target selection approaches, explore immune cell modulators, and gain valuable insights into target selection criteria and pre-clinical/clinical readouts. By participating in the summit, you will acquire a holistic understanding of the current state-of-play in the rapidly evolving bispecific landscape, empowering you to supercharge your own pipeline from the early stages of discovery to the achievement of Investigational New Drug (IND) approval.

Why Attend

14th World Bispecific Summit 2023

Stay ahead in the field of bispecific antibody development and therapeutics.

Grow

Deep dive into novel target selection, immune cell modulators, target selection and pre-clinical/clinical readouts and gain holistic insight of the current state-of-play in the bispecific landscape to supercharge your own pipeline from discovery through to IND approval.

Experience

Immerse yourself in a dynamic and collaborative environment, surrounded by experts and peers who are passionate about advancing bispecific antibody therapeutics.

Be inspired

Gain inspiration from keynote speakers who are at the forefront of bispecific antibody research and development. Hear their stories, learn from their experiences, and gain valuable insights into the future of this transformative field.

Similar Events

You May Like

Event

Hanson Wade
0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

02 - 04 Oct 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Alexander Schinagl
Co-Founder and Chief Technology Officer
Rakesh Dixit
President & Chief Scientific Officer
Anish Suri
President & Chief Scientific Officer
Arne Scheu
Co-Founder and Chief Executive Officer
Brad Lunde
Group Leader
Christoph Rader
Chief Technology Officer
Christopher Mehlin
Co-founder and Chief Scientific Officer
Ercole Rao
Group Leader
Hayretin Yumerefendi
Associate Director
Thomas Nittoli
Senior Director
Nina Weisser
Director - Multispecific Antibody Therapeutics
Qingcong Lin
CEO of Biocytogen Boston Corp

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Applied BioMath

Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development.

Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development.

Beacon Targeted Therapies

Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments.

Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments.

Carterra

Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates.

Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates.

BSP Pharmaceuticals S.p.A.

BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006.

BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006.

Creative Biolabs

Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and drug development.

Creative Biolabs is specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs of early drug discovery and drug development.

OmniAb, Inc.

The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

The OmniAb discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

Nicoya

Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed.Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease

Nicoya is a Canadian biotechnology company dedicated to improving human life by helping scientists succeed.Established in 2012, Nicoya was founded by Ryan Denomme in his relentless pursuit to use nanotechnology to increase the affordability and ease of use of scientific instruments.Within 10 years,

InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company established in 2004. Our team has been providing customers with QSP modeling services and tools for more than 10 years. We continuously develop our own QSP platforms and software infrastru

InSysBio is a Quantitative Systems Pharmacology (QSP) company established in 2004. Our team has been providing customers with QSP modeling services and tools for more than 10 years. We continuously develop our own QSP platforms and software infrastructure. We assist in making right decisions at crit

Organizer

All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.

Get emails from us

Thank you
Oops! Something went wrong